RecruitingNot ApplicableNCT05599698
Effects of Chemotherapy on Perceived Daily Performance and Executive Functions of Adults With Cancer
Sponsor
Bnai Zion Medical Center
Enrollment
38 participants
Start Date
Nov 15, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to examine changes in perceived daily performance and executive functioning following chemotherapy in individuals with non-central nervous system cancers.
Eligibility
Min Age: 18 YearsMax Age: 75 Years
Inclusion Criteria5
- Newly diagnosed with a primary non-central nervous system malignancy (lung, breast, colon, ulcer, urinary tract, canine tumors).
- Stages I-III.
- Pre-commencement of adjuvant (post-surgery) or neoadjuvant (prior to surgery) chemotherapy.
- Understand and read Hebrew.
- Have at least 12 years of education.
Exclusion Criteria4
- Diagnosed with central nervous system malignancies.
- Had a previous malignancy.
- Have or had metastatic disease.
- Have a history of a neurological condition or severe depression.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERChemotherapy
Standard chemotherapy protocols for adjuvant \& neoadjuvant treatment for different types of solid malignancies
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05599698
Related Trials
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
NCT067566071 location
A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
NCT055881411 location
Patient-Centered Assessment of Symptoms and Outcomes
NCT039526241 location
Tumor Related Epilepsy
NCT026393251 location
Improving Engagement in HIV and Cancer Care in Zimbabwe
NCT069343691 location